UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code |
( |
Not applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered |
ITEM 8.01. Other Events.
As previously reported, on November 10, 2022, Allied Healthcare Products, Inc. (the “Company”) convened its 2022 Annual Meeting of Stockholders (the “Annual Meeting”). At that time, there were not present or represented by proxy a sufficient number of shares of the Company’s common stock in order to constitute the required quorum. As a result, the Company adjourned the Annual Meeting until December 9, 2022 at 9:00 a.m. Central Time. As of such time, the Company still has not received proxies representing a sufficient number of shares of the Company’s common stock to constitute a quorum. As a result, the Company again adjourned the Annual Meeting until January 9, 2023 at 9:00 a.m. Central Time.
The information in this item 8.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by reference to such filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ALLIED HEALTHCARE PRODUCTS, INC. | ||
By: | ||
Date: December 12, 2022 | /s/ Daniel C. Dunn | |
Daniel C. Dunn | ||
Chief Financial Officer |
Cover |
Dec. 09, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Dec. 09, 2022 |
Entity File Number | 0-19266 |
Entity Registrant Name | ALLIED HEALTHCARE PRODUCTS, INC. |
Entity Central Index Key | 0000874710 |
Entity Tax Identification Number | 25-1370721 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 1720 Sublette Avenue |
Entity Address, City or Town | St. Louis |
Entity Address, State or Province | MO |
Entity Address, Postal Zip Code | 63110 |
City Area Code | 314 |
Local Phone Number | 771-2400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $.01 |
Trading Symbol | AHPI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
GR9URV,
M2R2=POPJ&4&G@&MVF?S:/&QV6];555T7/)]FQ^_%[4KPU?OD^L/O*FR]-GOS
MCXTO@ET+O_Y%]P502P,$% @ J66-59E -8?20$3;8T.P6BP^0"X99K>]9!:G
OJ =>Y3N3P$)"Y(+>!G]P/VX/\A0\JSSP+I6E).]6V1XIB[>DD%-&==Y3J,W(
MC6VJKL*!G+JA),@.)C=XXDJ6#L95#?B6.MA%IP*
UP1"AQ7#PCJ6$G[U084N&_,<3/U4+SP'-DW@:MB=*&7DLS
MB# 'F.O!#('AW.7,3^)?7 WSP1?7M-T^T.H 1H#LZGPO#)I0]